Description
Candesar (Candesartan Cilexetil) Tablets 16 mg. №10
Ingredients
Active ingredient: Candesartan Cilexetil 16 mg.
Mechanism of Action
Candesartan Cilexetil is a selective angiotensin II receptor blocker that lowers blood pressure by blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II.
Pharmacological Properties
Pharmacological Effects: Candesartan Cilexetil blocks the binding of angiotensin II to its receptors, leading to vasodilation, reduced secretion of aldosterone, decreased peripheral resistance, and lowered blood pressure.
Indications for Use
Indications: Candesar tablets are indicated for the treatment of hypertension to lower blood pressure.
Contraindications
Contraindications: Do not use Candesar if you are pregnant, have severe liver disease, or have a history of angioedema with previous use of ACE inhibitors.
Side Effects
Common side effects of Candesar may include dizziness, headache, fatigue, and cough. Contact your healthcare provider if you experience any severe side effects.
Usage Instructions
Dosage: The usual recommended dose is one 16 mg tablet taken once daily. Take Candesar tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water.
Benefits Compared to Analogues
Candesar has shown similar efficacy to other angiotensin II receptor blockers in lowering blood pressure with a lower risk of certain side effects.
Suitable Patient Groups
Candesar is suitable for adult patients with hypertension. Dosage adjustments may be necessary for elderly patients based on individual health conditions.
Storage and Shelf Life
Store Candesar tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product if expired.
Packaging Description
Candesar tablets are packaged in blister packs containing 10 tablets each. The packaging is designed to protect the tablets from moisture and external factors.
Clinical Evidence and Proven Effectiveness
Clinical Trials: Clinical trials have demonstrated the efficacy of candesartan cilexetil in reducing cardiovascular events and mortality in patients with hypertension. A study published in the Journal of the American Medical Association (JAMA) showed that candesartan significantly reduced the risk of stroke compared to placebo.
